Menu Search
Equities

Guardian Pharmacy Services Inc

GRDN:NYQ

Guardian Pharmacy Services Inc

Actions
  • Price (USD)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Guardian Pharmacy Services, Inc. is a pharmacy services company. The Company provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. Through its locally based pharmacies, the Company utilizes a complex, technology-enabled platform to manage the dispensing and administration of prescriptions to residents of LTCFs over the full prescription lifecycle to manage medication risk. Its services include resident & family resources, assisted living and memory care, skilled nursing, mental and behavioural health, intellectual and developmental disabilities, hospice care, program of all-inclusive care for the elderly (PACE), GuardianShield, and eMAR / EHR Partners. Its Guardian Compass platform offers insights to enhance efficiencies for pharmacies, including proprietary real-time operational dashboards and metrics.

  • Revenue in -- (TTM)--
  • Net income in --
  • Incorporated2021
  • Employees--
  • Location
    Guardian Pharmacy Services Inc300 Galleria Parkway SE, Suite 800ATLANTA 30339United StatesUSA
  • Phone+1 (404) 810-0089
  • Websitehttps://guardianpharmacy.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.